acquired
Stage
2013
Founded
2
Investors
About
Translate Bio was a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of medicines to treat diseases caused by protein or gene dysfunction. It focused on creating transformative treatments using its mRNA platform.
Explore Translate Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.